High prescription drug costs are facing greater oversight at the state level as Virginia lawmakers charge ahead with measures to lower prices, joining a handful of states already at odds with the pharmaceutical industry.
Virginia is on a path toward joining around a dozen other states that have enacted prescription drug affordability boards or something like them. PDABs, as they’re known, come with a variety of powers.
Some, like Minnesota and Maryland, can set upper payment limits for drugs—an authority that has spurred drugmaker litigation against Colorado that could have a ripple effect. Others, like Maine and New Hampshire, can ...